By the 5th of March it was officially announced that Laboratorium Ofichem receives an approval for the “Certificate of Suitability” (CEP) request for Pamidronate Disodium Pentahydrate.
ZEMBLA investigated the shortage of medicines in the Netherlands, which may be a result of the changing production conditions in China. In preparation for this broadcast, ZEMBLA also interviewed Dr Weite Oldenziel, CEO of the Ofichem group.
The local news paper ‘Dagblad van het Noorden’ has published an article about TheLeann.
Recently the Ofichem Group has launched their new corporate identity.
This year the Ofichem Group will also be present at CPhI.
Recently the Ofichem Group has opened a new office in Ter Apel.
[ Placeholder content for popup link ] WordPress Download Manager - Best Download Management Plugin